Why Credit Corp, GUD, Race Oncology, and Spartan Resources shares are rising

These shares are having a decent session. But why?

| More on:
A man sees some good news on his phone and gives a little cheer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a tough session on Tuesday. In afternoon trade, the benchmark index is down 0.4% to 7,719.1 points.

Four ASX shares that are not letting that hold them back today are listed below. Here's why they are rising:

Credit Corp Group Limited (ASX: CCP)

The Credit Corp share price is up almost 4% to $15.44. Investors have been buying this debt collector's shares on Tuesday after they were the subject of a bullish broker note out of Macquarie. According to the note, the broker has upgraded Credit Corp's shares to an outperform rating with an $18.32 price target. Macquarie highlights that the company's shares are trading at a deep discount to long term multiples. It feels this make now an opportune time for investors to initiate an investment. And judging by its gain today, it seems that the investors agree.

GUD Holdings Limited (ASX: GUD)

The GUD Holdings share price is up 11.5% to $10.90. This has been driven by the release of a trading update from the auto parts company. Management revealed that it remains on course to achieve its guidance in FY 2024. This will mean underlying earnings before interest, taxes and amortisation (EBITA) of at least $193.5 million. That's despite its AutoPacific Group (APG) segment performing a touch below expectations. Management revealed that this reflects the ongoing execution of its diversification strategy and the resilience of the aftermarket parts market.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is up 8% to $1.67. This follows the release of results from recent preclinical work performed under contract at Oncolines in the Netherlands. The release notes that in these studies, its bisantrene product was screened in combination with decitabine for enhanced anticancer activity across a broad panel of 143 cancer cell lines. Race CEO, Dr Daniel Tillett, commented: "These results open exciting new treatment opportunities for both bisantrene and decitabine."

Spartan Resources Ltd (ASX: SPR)

The Spartan Resources share price is up 3% to 65.3 cents. This morning, this gold developer revealed that it has completed the retail component of its fully underwritten pro rata accelerated non-renounceable entitlement offer. The retail entitlement offer raised a total of approximately $11 million at the offer price of 58 cents per new share. This brings the total raised to approximately $80 million. Proceeds will be used to underpin a significantly expanded exploration campaign at the Dalgaranga Gold Project.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a spectacular end to the trading week for the ASX today.

Read more »

Three people jumping cheerfully in clear sunny weather.
Share Gainers

These 3 ASX 200 stocks are shooting the lights out this week. Own any?

These ASX 200 shares have soared 11% to almost 23% this week. But why?

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Share Gainers

Why GQG, Imugene, Mirvac, and Temple & Webster shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a momentous day for ASX shares, with the index hitting another record...

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why ASX, Domain, Ora Banda, and Temple & Webster's shares are storming higher today

These shares are catching the eye with strong gains on Thursday. Let's see what is happening.

Read more »

Man pointing at a blue rising share price graph.
Earnings Results

2 ASX 300 shares rocketing 6% today

Investors love what these two stocks just reported.

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wonderful Wednesday session for investors today...

Read more »